Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors

WOBURN, Massachusetts, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Hyam I. Levitsky, M.D. to the company's ... Biopharmaceuticals, Oncology, Personnel Replimune, Immulytic, immunotherapy, immunotherapeutic
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news